- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 47.34M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 47.22M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 44.34M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.06M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$709K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $3.08M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $5.14M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.49M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $4.57M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $4.25M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $4.71M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.01M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $605K |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.01M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $605K |
| Current Assets | Q1 2026 · Mar 31, 2026 | $3.5M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $5.17M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $3.5M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $5.17M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.05 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.11 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.05 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.11 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.28M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $336K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $679K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $4.72M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.54M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$5.05M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.96M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$5.05M |